Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Researchers are already testing triple-agonist drugs, such as retatrutide, which target GLP-1, GIP and glucagon receptors
Ready to take the first step towards a healthier, happier you
Community-reported protocols start at 0.250.5 mg/week and titrate to 1.54 mg/week over 812 weeks as GI tolerance is assessed
Given the higher risk associated with SO for functional capacity decline, cardiovascular health, and all-cause mortality, it is anticipated that SO may result in more severe public health consequences than obesity alone [10]
Blood work every 6-12 weeks during active weight loss phases helps ensure appropriate thyroid hormone levels
Communication with your partner about your goals and the treatment process helps align expectations
US$ 19.98
US$ 25.95
US$ 23.72
US$ 25.11
US$ 25.12
US$ 23.14
US$ 28.12
